Last reviewed · How we verify

NCT05570019: EVTI-PAD

Evaluation of Tissue Perfusion in Peripheral Arterial Disease (EVTI-PAD)

Status unknown Last updated 13 March 2024
What this trial tests

trial testing Revascularization in Peripheral Arterial Disease in 200 participants. Status unknown.

Timeline
1 October 2022
Primary endpoint
30 September 2024
31 December 2024

Quick facts

Lead sponsorMedical University Innsbruck
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date1 October 2022
Primary completion30 September 2024
Estimated completion31 December 2024
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

Medical University Innsbruck

Who can join

18 and older, any sex, with Peripheral Arterial Disease or Chronic Limb-Threatening Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective single-center observational study, arterial perfusion in patients with lower limb peripheral arterial disease will be assessed with standard diagnostic tools (toe pressure, trans-cutaneous oxygen pressure, ankle-brachial index and fluorescence angiography) before and after standard revascularization procedures (open surgery and/or angioplasty).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Fluorescence imaging for assessing tissue perfusion after revascularization in peripheral arterial disease.
    Kluckner M, von Kroge PH, Duprée A, Wippel D, et al · · 2026 · PMID 41933212 · DOI 10.1038/s41598-026-47505-7
  2. Real-Time Perfusion Assessment with Hyperspectral Imaging After Revascularization in Peripheral Artery Disease
    Kluckner M, Hitzl W, Enzmann F, Wippel D, et al · · 2026

Verify or expand the search:

Other trials of Revascularization

Trials testing the same drug.

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

Other Medical University Innsbruck trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05570019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing